iShares Global Healthcare ETF (IXJ) Holdings
IXJ holdings summary
as of Oct 25, 2026- Holdings
- 108 positions listed
- Top 10 weight
- 47.2% of net assets
- Effective holdings
- 30 equal-weight equivalent
- Largest holding
- LLY 10.83% Eli Lilly and Company
- Annual turnover
- 2.9% of the portfolio traded
Top 1047.2%
Top 2569.9%
Top 5086.1%
Top 10098.4%
All IXJ holdings
108 holdings
| # | Name | ||||||
|---|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | Healthcare | 10.83% | $488.7M | $1.12T | 42.2 |
| 2 | JNJ | Johnson & Johnson | Healthcare | 6.70% | $302.1M | $615.87B | 38.8 |
| 3 | ABBV | AbbVie Inc. | Healthcare | 5.40% | $243.6M | $504.37B | 80.6 |
| 4 | UNH | UnitedHealth Group Incorporated | Healthcare | 4.38% | $197.3M | $360.32B | 25.8 |
| 5 | MRK | Merck & Co., Inc. | Healthcare | 4.19% | $189.2M | $360.08B | 115.8 |
| 6 | ROP | Roche Holding AG | Healthcare | 3.85% | $173.5M | — | — |
| 7 | NOVN | Novartis AG | Healthcare | 3.15% | $142.2M | — | — |
| 8 | AZN | AstraZeneca PLC | Healthcare | 3.05% | $137.6M | — | — |
| 9 | TMO | Thermo Fisher Scientific Inc. | Healthcare | 2.91% | $131.4M | $255.13B | 37.1 |
| 10 | AMGN | Amgen Inc. | Healthcare | 2.70% | $121.7M | $233.82B | 26.9 |
| 11 | GILD | Gilead Sciences, Inc. | Healthcare | 2.18% | $98.4M | $193.67B | — |
| 12 | PFE | Pfizer Inc. | Healthcare | 2.08% | $93.9M | $168.60B | 38.9 |
| 13 | ABT | Abbott Laboratories | Healthcare | 1.95% | $87.8M | $181.50B | 33.8 |
| 14 | ISRG | Intuitive Surgical, Inc. | Healthcare | 1.74% | $78.4M | $150.74B | 48.9 |
| 15 | DHR | Danaher Corporation | Healthcare | 1.62% | $72.9M | $161.01B | 40.8 |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | Healthcare | 1.56% | $70.4M | $126.66B | 28.9 |
| 17 | BMY | Bristol-Myers Squibb Company | Healthcare | 1.47% | $66.3M | $122.05B | 13.2 |
| 18 | NOVO-B | Novo Nordisk A/S | Healthcare | 1.45% | $65.2M | — | — |
| 19 | CVS | CVS Health Corporation | Healthcare | 1.44% | $65.1M | $118.13B | 24.3 |
| 20 | MCK | McKesson Corporation | Healthcare | 1.36% | $61.5M | $117.15B | 26.9 |
| 21 | MDT | Medtronic plc | Healthcare | 1.34% | $60.6M | $121.20B | 23.3 |
| 22 | GSK | GSK plc | Healthcare | 1.24% | $55.9M | — | — |
| 23 | SYK | Stryker Corporation | Healthcare | 1.18% | $53.0M | $113.02B | 30.5 |
| 24 | ELV | Elevance Health Inc. | Healthcare | 1.08% | $48.8M | $92.88B | 19.0 |
| 25 | SAN | Sanofi SA | Healthcare | 1.02% | $46.2M | — | — |
| 26 | CI | Cigna Corporation | Healthcare | 0.97% | $43.6M | $79.88B | 12.5 |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | Healthcare | 0.95% | $42.7M | $81.41B | 19.6 |
| 28 | MRNA | Moderna, Inc. | Healthcare | 0.91% | $41.0M | $87.04B | — |
| 29 | HCA | HCA Healthcare, Inc. | Healthcare | 0.79% | $35.8M | $99.34B | 15.4 |
| 30 | COR | Cencora | Healthcare | 0.77% | $34.7M | $65.06B | 25.3 |
| 31 | 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | 0.75% | $33.9M | — | — |
| 32 | BSX | Boston Scientific Corporation | Healthcare | 0.73% | $33.1M | $64.33B | 18.0 |
| 33 | CSL | CSL Ltd | Healthcare | 0.73% | $32.9M | — | — |
| 34 | 7741 | Hoya Cor | Healthcare | 0.66% | $29.9M | — | — |
| 35 | CAH | Cardinal Health, Inc. | Healthcare | 0.66% | $29.7M | $58.83B | 35.1 |
| 36 | EL | EssilorLuxottica S. A. | Healthcare | 0.65% | $29.3M | — | — |
| 37 | BDX | Becton, Dickinson and Company | Healthcare | 0.60% | $27.2M | $52.23B | 44.6 |
| 38 | ARGX | Argen-X | Healthcare | 0.60% | $27.2M | — | — |
| 39 | LONN | Lonza Group AG | Healthcare | 0.59% | $26.5M | — | — |
| 40 | HUM | Humana Inc. | Healthcare | 0.58% | $26.3M | $49.61B | 39.1 |
| 41 | EW | Edwards Lifesciences Corporation | Healthcare | 0.58% | $26.3M | $49.92B | 51.5 |
| 42 | BAYN | Bayer AG NA | Healthcare | 0.55% | $25.0M | — | — |
| 43 | VEEV | Veeva Systems Inc. | Healthcare | 0.55% | $24.8M | $50.25B | 50.9 |
| 44 | A | Agilent Technologies, Inc. | Healthcare | 0.54% | $24.6M | $48.77B | 34.1 |
| 45 | HLN | Haleon PLC | Healthcare | 0.54% | $24.4M | — | — |
| 46 | IQV | IQVIA Holdings Inc. | Healthcare | 0.54% | $24.4M | $43.93B | 33.2 |
| 47 | WAT | Waters Corporation | Healthcare | 0.51% | $23.1M | $42.90B | 110.6 |
| 48 | IDXX | IDEXX Laboratories, Inc. | Healthcare | 0.51% | $23.1M | $44.20B | 39.8 |
| 49 | SDZ | Sandoz Group AG | Healthcare | 0.49% | $22.2M | — | — |
| 50 | GALD | Galderma Group N | Healthcare | 0.49% | $22.1M | — | — |
| 51 | ILMN | Illumina, Inc. | Healthcare | 0.46% | $20.6M | $39.64B | 49.0 |
| 52 | BIIB | Biogen Inc. | Healthcare | 0.45% | $20.2M | $34.37B | 41.3 |
| 53 | RMD | ResMed Inc. | Healthcare | 0.43% | $19.5M | $33.61B | 22.9 |
| 54 | 4578 | Otsuka Holdings Ltd | Healthcare | 0.42% | $19.0M | — | — |
| 55 | ALC | Alcon AG | Healthcare | 0.42% | $19.0M | — | — |
| 56 | 4568 | Daiichi Sankyo Co. Ltd. | Healthcare | 0.40% | $18.2M | — | — |
| 57 | CNC | Centene Corporation | Healthcare | 0.39% | $17.8M | $34.16B | — |
| 58 | UCB | UCB SA | Healthcare | 0.39% | $17.5M | — | — |
| 59 | ZTS | Zoetis Inc. | Healthcare | 0.39% | $17.4M | $32.80B | 13.1 |
| 60 | MTD | Mettler-Toledo International Inc. | Healthcare | 0.38% | $17.1M | $32.51B | 36.6 |
| 61 | GEHC | GE HealthCare Technologies Inc. | Healthcare | 0.37% | $16.7M | $31.42B | 16.0 |
| 62 | 4503 | Astellas Pharma Inc. | Healthcare | 0.33% | $14.9M | — | — |
| 63 | WST | West Pharmaceutical Services, Inc. | Healthcare | 0.33% | $14.8M | $27.03B | 49.4 |
| 64 | DXCM | DexCom, Inc. | Healthcare | 0.33% | $14.8M | $32.47B | 34.1 |
| 65 | 6160 | BeOne Medicines AG | Healthcare | 0.32% | $14.6M | — | — |
| 66 | DGX | Quest Diagnostics Incorporated | Healthcare | 0.30% | $13.7M | $25.94B | 24.6 |
| 67 | 4519 | Chugai Pharmaceutical Co. Ltd. | Healthcare | 0.30% | $13.7M | — | — |
| 68 | GMAB | Genmab A/S | Healthcare | 0.30% | $13.4M | — | — |
| 69 | LH | Laboratory Corporation of America Holdings | Healthcare | 0.30% | $13.3M | $25.79B | 26.3 |
| 70 | STE | STERIS plc | Healthcare | 0.27% | $12.0M | $21.71B | 27.2 |
| 71 | 4543 | Terumo Corp. | Healthcare | 0.26% | $11.7M | — | — |
| 72 | MRK | Merck KGaA | Healthcare | 0.26% | $11.5M | — | — |
| 73 | VTRS | Viatris Inc. | Healthcare | 0.25% | $11.5M | $21.43B | — |
| 74 | FRE | Fresenius SE & Co. KGaA | Healthcare | 0.25% | $11.3M | — | — |
| 75 | PHIA | Koninklijke Philips NV | Healthcare | 0.23% | $10.6M | — | — |
| 76 | INCY | Incyte Corporation | Healthcare | 0.23% | $10.5M | $22.92B | 14.4 |
| 77 | ZBH | Zimmer Biomet Holdings, Inc. | Healthcare | 0.22% | $10.1M | $18.12B | 23.1 |
| 78 | SOON | Sonova H Ag | Healthcare | 0.20% | $9.1M | — | — |
| 79 | RVTY | Revvity, Inc. | Healthcare | 0.20% | $9.0M | $17.03B | 73.0 |
| 80 | SHL | Siemens Healthineers AG | Healthcare | 0.19% | $8.7M | — | — |
| 81 | 4507 | Shionogi & Co. Ltd. | Healthcare | 0.18% | $8.2M | — | — |
| 82 | CRL | Charles River Laboratories International, Inc. | Healthcare | 0.18% | $8.1M | $14.46B | — |
| 83 | RO | Roche Holding AG | Healthcare | 0.17% | $7.5M | — | — |
| 84 | STMN | Straumann Holding AG | Healthcare | 0.16% | $7.1M | — | — |
| 85 | BAX | Baxter International Inc. | Healthcare | 0.16% | $7.0M | $13.07B | — |
| 86 | SOLV | Solventum Corporation | Healthcare | 0.15% | $6.8M | $14.61B | 10.5 |
| 87 | SN | Smith & Nephew PLC | Healthcare | 0.15% | $6.7M | — | — |
| 88 | 7733 | Olympus Corp. | Healthcare | 0.14% | $6.3M | — | — |
| 89 | COO | The Cooper Companies, Inc. | Healthcare | 0.14% | $6.3M | $11.02B | 19.9 |
| 90 | SIG | Sigma Healthcare Ltd | Healthcare | 0.13% | $6.0M | — | — |
| 91 | TECH | Bio-Techne Corporation | Healthcare | 0.13% | $5.7M | $11.38B | 62.6 |
| 92 | QIA | QIAGEN NV | Healthcare | 0.12% | $5.6M | — | — |
| 93 | UHS | Universal Health Services, Inc. | Healthcare | 0.12% | $5.2M | $10.91B | 7.6 |
| 94 | ALGN | Align Technology, Inc. | Healthcare | 0.11% | $5.2M | $10.46B | 25.6 |
| 95 | PODD | Insulet Corporation | Healthcare | 0.11% | $5.2M | $9.79B | 26.4 |
| 96 | ERF | Eurofins Scientific SE | Healthcare | 0.11% | $5.1M | — | — |
| 97 | 4523 | Eisai Co. Ltd. | Healthcare | 0.11% | $5.0M | — | — |
| 98 | COLO-B | Coloplast A/S | Healthcare | 0.10% | $4.7M | — | — |
| 99 | RDOR3 | Rede D'Or São Luiz S.A. | Healthcare | 0.10% | $4.7M | — | — |
| 100 | FME | Fresenius Medical Care AG & Co. KGaA | Healthcare | 0.10% | $4.4M | — | — |
| 101 | HSIC | Henry Schein, Inc. | Healthcare | 0.10% | $4.3M | $9.63B | 25.2 |
| 102 | SRT3 | Sartorius Aktiengesellschaft | Healthcare | 0.09% | $4.1M | — | — |
| 103 | 4528 | Ono Pharmaceutical Ltd | Healthcare | 0.08% | $3.8M | — | — |
| 104 | SHL | Sonic Healthcare Ltd | Healthcare | 0.08% | $3.5M | — | — |
| 105 | COH | Cochlear Ltd | Healthcare | 0.07% | $3.3M | — | — |
| 106 | DIM | Sartorius Stedim Biotech SA | Healthcare | 0.07% | $3.3M | — | — |
| 107 | DVA | DaVita Inc. | Healthcare | 0.07% | $3.1M | $11.95B | 15.8 |
| 108 | GETI-B | Getinge AB ser. B | Healthcare | 0.07% | $3.1M | — | — |
Weights as a percentage of net assets. Value held = weight × net assets ($4.51B). Market cap and P/E from each company's latest fundamentals (U.S.-listed stocks).
IXJ sector breakdown
Sum of the weights of the holdings in each sector.
IXJ top industries
Drug Manufacturers - General
52.0%
Diagnostics & Research
9.4%
Healthcare Plans
8.8%
Medical Devices
8.4%
Biotechnology
6.1%
Medical Instruments & Supplies
5.8%
Drug Manufacturers - Specialty & Generic
3.5%
Medical Distribution
3.0%
Medical Care Facilities
1.4%
Health Information Services
0.6%
IXJ overlap with other ETFs
| ETF | Fund | Overlap | Shared holdings | Expense ratio |
|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | 73.1% | 60 of 60 | 0.09% |
| TRUH | VanEck Healthcare TruSector ETF | 73.1% | 60 of 60 | — |
| FHLC | Fidelity MSCI Health Care ETF | 73.1% | 60 of 334 | 0.07% |
| VHT | Vanguard Health Care ETF | 73.1% | 60 of 406 | 0.10% |
| IYH | iShares U.S. Healthcare ETF | 68.5% | 55 of 99 | 0.39% |
| RXL | ProShares Ultra Health Care | 63.0% | 60 of 61 | 0.93% |
Overlap = sum over shared holdings of the smaller of the two weights. 100% means identical portfolios.
About the IXJ portfolio
iShares Global Healthcare ETF holds 108 positions. The ten largest make up 47.2% of the fund and the top 50 86.1%, so it behaves like a portfolio of about 30 equally weighted stocks. The biggest positions are Eli Lilly and Company (10.83%), Johnson & Johnson (6.70%), AbbVie Inc. (5.40%), UnitedHealth Group Incorporated (4.38%), Merck & Co., Inc. (4.19%).
By sector, Healthcare is 99.0%. Holdings data is from the fund's latest portfolio as reported by EODHD on October 25, 2026; positions change as the fund rebalances.
Related: IXJ chart, IXJ performance, IXJ dividends, IXJ valuation, IXJ overview.
IXJ holdings FAQ
How many holdings does IXJ have?
IXJ holds 108 positions as of October 25, 2026.
What are the top 10 holdings of IXJ?
The ten largest holdings are Eli Lilly and Company (10.83%), Johnson & Johnson (6.70%), AbbVie Inc. (5.40%), UnitedHealth Group Incorporated (4.38%), Merck & Co., Inc. (4.19%), Roche Holding AG (3.85%), Novartis AG (3.15%), AstraZeneca PLC (3.05%), Thermo Fisher Scientific Inc. (2.91%), Amgen Inc. (2.70%). Together they are 47.2% of the fund.
What percentage of IXJ is Eli Lilly and Company?
Eli Lilly and Company is the largest holding at 10.83% of net assets, about $488.7M of the fund's $4.51B.
How concentrated is IXJ?
The top 10 holdings are 47.2% of the fund. By the effective number of holdings (1 divided by the sum of squared weights) IXJ behaves like a portfolio of about 30 equally weighted stocks.